Literature DB >> 14986031

E-cadherin expression is homogeneously reduced in adenoma from patients with familial adenomatous polyposis: an immunohistochemical study of E-cadherin, beta-catenin and cyclooxygenase-2 expression.

M Jungck1, F Grünhage, U Spengler, A Dernac, M Mathiak, R Caspari, W Friedl, T Sauerbruch.   

Abstract

BACKGROUND AND AIMS: The adenomatous polyposis coli (APC) protein plays a crucial role in the regulation of beta-catenin, which is linked to the cell adhesion molecule E-cadherin. Furthermore, beta-catenin and cyclooxygenase-2 (COX-2) are both involved in the activation of nuclear transcription factors inducing cell proliferation. Germline mutations in the APC gene are the cause of familial adenomatous polyposis (FAP). To characterise the expression pattern of these proteins in FAP in comparison with sporadic adenomas, we studied 18 FAP-associated adenomas, 16 sporadic adenomas and seven normal colonic controls.
METHODS: E-cadherin, beta-catenin, COX-2 expression and the proliferative index (Ki67) were assessed by immunohistochemistry (index of expressing cells / total number of cells) in adenomatous mucosa, adjacent non-neoplastic tissue and normal colonic controls.
RESULTS: E-cadherin expression was significantly and homogeneously reduced in FAP adenomas (24%; 95%CI 16-32; sporadic adenomas 61%; 38-84; normal controls 98%; 96-100). Membraneous beta-catenin expression was significantly reduced in both FAP (30%; 11-49) and sporadic (42%; 19-65) adenomas (normal controls 96%; 88-104), whereas marked nuclear staining occurred in sporadic, but not in FAP adenomas. Stromal COX-2 expression and the proliferative index were increased only in sporadic adenomas (sporadic adenomas: COX-2 12%; 7-17, Ki67 24%; 15-33, FAP adenomas: COX-2 8%; 5-11, Ki67 5%; 2-9, normal controls: COX-2 4%; 2-7, Ki67 6%; 1-11).
CONCLUSION: Proteins involved in cell adhesion and cell proliferation, especially E-cadherin, are expressed differently in FAP and sporadic adenoma, pointing to possible differences in the molecular pathways to adenoma. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14986031     DOI: 10.1007/s00384-003-0575-z

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  28 in total

Review 1.  Linking colorectal cancer to Wnt signaling.

Authors:  M Bienz; H Clevers
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  Expression of E-cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120) in colorectal polyps.

Authors:  A Valizadeh; A J Karayiannakis; I el-Hariry; W Kmiot; M Pignatelli
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

4.  High expression of cyclooxygenase-2 in macrophages of human colonic adenoma.

Authors:  H Bamba; S Ota; A Kato; A Adachi; S Itoyama; F Matsuzaki
Journal:  Int J Cancer       Date:  1999-11-12       Impact factor: 7.396

5.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

6.  Intracellular distribution of beta-catenin in colorectal adenomas, carcinomas and Peutz-Jeghers polyps.

Authors:  P Herter; C Kuhnen; K M Müller; A Wittinghofer; O Müller
Journal:  J Cancer Res Clin Oncol       Date:  1999       Impact factor: 4.553

7.  The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis.

Authors:  N N Mahmoud; S K Boolbol; A J Dannenberg; J R Mestre; R T Bilinski; C Martucci; H L Newmark; A Chadburn; M M Bertagnolli
Journal:  Carcinogenesis       Date:  1998-01       Impact factor: 4.944

8.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway.

Authors:  M Shtutman; J Zhurinsky; I Simcha; C Albanese; M D'Amico; R Pestell; A Ben-Ze'ev
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 9.  Emerging concepts in colorectal neoplasia.

Authors:  Jeremy R Jass; Vicki L J Whitehall; Joanne Young; Barbara A Leggett
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

10.  Nuclear translocation of beta-catenin in colorectal cancer.

Authors:  M Kobayashi; T Honma; Y Matsuda; Y Suzuki; R Narisawa; Y Ajioka; H Asakura
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

View more
  5 in total

1.  Targeted Cox2 gene deletion in intestinal epithelial cells decreases tumorigenesis in female, but not male, ApcMin/+ mice.

Authors:  Durga P Cherukuri; Tomo-O Ishikawa; Patrick Chun; Art Catapang; David Elashoff; Tristan R Grogan; James Bugni; Harvey R Herschman
Journal:  Mol Oncol       Date:  2013-11-08       Impact factor: 6.603

2.  Down-regulation of CDH1 is associated with expression of SNAI1 in colorectal adenomas.

Authors:  Feride Kroepil; Georg Fluegen; Zaurbek Totikov; Stephan E Baldus; Christian Vay; Matthias Schauer; Stefan A Topp; Jan Schulte Am Esch; Wolfram T Knoefel; Nikolas H Stoecklein
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

3.  Gene expression profiling in familial adenomatous polyposis adenomas and desmoid disease.

Authors:  Nikola A Bowden; Amanda Croft; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2007-06-15       Impact factor: 2.857

4.  Cyclooxygenase-2 expression is related to the epithelial-to-mesenchymal transition in human colon cancers.

Authors:  Tae Jung Jang; Kyu Ha Jeon; Ki Hoon Jung
Journal:  Yonsei Med J       Date:  2009-12-18       Impact factor: 2.759

5.  Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls.

Authors:  Bjorn W H van Heumen; Hennie M J Roelofs; René H M te Morsche; Fokko M Nagengast; Wilbert H M Peters
Journal:  Orphanet J Rare Dis       Date:  2013-11-19       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.